Literature DB >> 862628

Factor XIII and fracture healing. An experimental study.

J Benfer, H Struck.   

Abstract

The effect of exogenous factor XIII on fracture healing has been tested. It could be shown that after administration of the fibrin stabilizing factor, the concentration of fibrin fibres in the fracture haematoma increases. The resistance against breaking is thus enhanced in treated animals as compared to untreated controls, mainly during the early phases of fracture healing. X-ray diagnosis demonstrated an enhanced healing process of the treated fractures. The accelerated fracture healing by factor XIII adminstration could also be substantiated through histological examinations.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 862628     DOI： 10.1159/000127940

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN： 0014-312X            Impact factor:   1.745


  5 in total

1.  Experimental studies on the influence of fibrin adhesive, factor XIII, and calcitonin on the incorporation and remodeling of autologous bone grafts.

Authors:  H Gerngross; C Burri; L Claes
Journal:  Arch Orthop Trauma Surg       Date:  1986

2.  Fracture healing under factor XIII medication.

Authors:  O Hellerer; W L Brückner; K W Frey; K W Westerburg; U Klessinger
Journal:  Arch Orthop Trauma Surg       Date:  1980

3.  Recombinant factor XIII improves established experimental colitis in rats.

Authors:  G D'Argenio; A Grossman; V Cosenza; N D Valle; G Mazzacca; P D Bishop
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

4.  Osteopromotion with a plasmatransglutaminase on a beta-TCP ceramic.

Authors:  Stephan Becker; Otto Maissen; Igor Ponomarev; Thierry Stoll; Thomas Meury; Christoph Sprecher; Mauro Alini; Ingo Wilke
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

Review 5.  The impact of acquired coagulation factor XIII deficiency in traumatic bleeding and wound healing.

Authors:  Christian Kleber; Armin Sablotzki; Sebastian Casu; Martin Olivieri; Kai-Martin Thoms; Johannes Horter; Felix C F Schmitt; Ingvild Birschmann; Dietmar Fries; Marc Maegele; Herbert Schöchl; Michaela Wilhelmi
Journal:  Crit Care       Date:  2022-03-24       Impact factor: 19.334
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.